FPC
NEOS

Falcon Point Capital’s Neos Therapeutics, Inc NEOS Stock Holding History

Falcon Point Capital’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-72,201
Closed -$350K – 114
2018
Q3 		$350K Sell
72,201
-270,420
-79% -$1.53M 0.08% 85
2018
Q2 		$2.14M Sell
342,621
-50,891
-13% -$379K 0.42% 53
2018
Q1 		$3.27M Buy
393,512
+328,982
+510% +$3.14M 0.65% 47
2017
Q4 		$658K Sell
64,530
-51,339
-44% -$493K 0.11% 88
2017
Q3 		$1.21M Sell
115,869
-5,694
-5% -$43.3K 0.18% 76
2017
Q2 		$887K Buy
121,563
+33,284
+38% +$251K 0.12% 89
2017
Q1 		$636K Buy
88,279
+2,691
+3% +$16.7K 0.08% 97
2016
Q4 		$501K Buy
85,588
+16,453
+24% +$111K 0.07% 93
2016
Q3 		$408K Buy
+69,135
New +$548K 0.06% 91

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Falcon Point Capital's NEOS Position: Q4 2018 in Review

Falcon Point Capital sold out of Neos Therapeutics, Inc (NEOS) in Q4 2018, closing a stake of 72,201 shares — an estimated $350K sold.

Falcon Point Capital first reported a position in NEOS in Q3 2016 and held it in 9 quarters. The position peaked at $3.27M in Q1 2018. 63 funds tracked by Wall St. Rank hold NEOS as of Q4 2018.

  • Falcon Point Capital reported no remaining Neos Therapeutics, Inc position as of Q4 2018 after selling out during the quarter.
  • Falcon Point Capital sold 72,201 Neos Therapeutics, Inc shares in Q4 2018, an estimated $350K.
  • Falcon Point Capital first reported a position in Neos Therapeutics, Inc in Q3 2016 and held it in 9 quarters.
  • Falcon Point Capital's Neos Therapeutics, Inc position peaked at $3.27M in Q1 2018.
  • 63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2018.

Based on Falcon Point Capital's 13F filing for Q4 2018, filed 31 Jan 2019.